Exostemtech said it applied for a phase 1 trial of EST-P-EXO1, an osteoarthritis treatment candidate, to the Food and Drug Safety Ministry. If the company gets the nod for the ...
Read More »EXOSOME NEWS
Particles released by red blood cells are effective carriers for anti-cancer immunotherapy
A study demonstrated that vesicles released by red blood cells are a viable platform for delivering immunotherapeutic RNA molecules to suppress...
Read More »ILIAS Biologics Receives HREC Approval to Initiate First-in-Human Clinical Trial Evaluating Exosome Therapeutics ILB-202, the Treatment for CSA-AKI
ILIAS Biologics Inc., a biotech company dedicated to developing a new treatment modality, engineered exosome therapeutics, announced today that it has...
Read More »Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome
Tumor associated macrophages (TAMs), which differentiate from circulating monocytes, are pervasive across human cancers and comprise heterogeneous populations. The contribution of tumor-derived signals to TAM heterogeneity is not well understood. ...
Read More »Cells’ “exosomes” may improve the delivery of anticancer drugs to tumors
Researchers used exosomes produced by cells called adipose-derived mesenchymal stem cells (ADSCs) to deliver an RNA-based anti-cancer treatment...
Read More »A novel strategy that enables long-term spatial retention of extracellular vesicles
Collaborative research from CMU yields a novel strategy that enables long-term spatial retention of extracellular vesicles, a key variable to enable future tissue engineering and regenerative medicine applications. Leveraging unique expertise in the spirit of...
Read More »Untouched isolation enables targeted functional analysis of tumour-cell-derived extracellular vesicles from tumour tissues
To accurately identify the functions of tumour-cell-derived extracellular vesicles (T-EVs), EVs directly isolated from tumour tissues are much preferred over those derived from in vitro cultured tumour cell lines..
Read More »A functional corona around extracellular vesicles
Nanoparticles can acquire a plasma protein corona defining their biological identity. Corona functions were previously considered for cell-derived extracellular vesicles (EVs). Researchers at...
Read More »Extracellular vesicles and their microRNA cargo in ischaemic stroke
Acute ischaemic stroke (AIS) is a leading cause of death and disability. MicroRNAs (miRNAs) are short non-coding RNAs which hold the potential to act as...
Read More »Jobs
-
Featured Exosome Job – Scientist, Regenerative Medicine – Exosomes
Contribute to our expanding range of translational preventive and regenerative medicine work with exosomes from different source cells, including iPSCs and many iPSC-derived cell types like MSCs, HSCs,...
Read More » -
Post-doc position available – Clinical and Translational Research
-
Featured Exosome Job – Research Associate II, Exosome Engineering, Protein Sciences
-
Postdoc position available – microchip-based exosome sensors
-
Post-doc position available – new pathways in endosome formation and extracellular vesicle secretion in metastasis
Industry News
-
Coya Therapeutics Secures Option Agreement for Exclusive Worldwide Rights to Exosome Engineering Technology from Carnegie Mellon University
Coya Therapeutics announced the execution of an option agreement for exclusive worldwide rights to a novel and proprietary technology platform enabling...
Read More » -
Exosome Engineering Strategies for Cargo Loading and Targeting Delivery
-
Coya Therapeutics Secures $10 Million Financing to Advance Clinical and Pre-Clinical Pipeline of Treg-Derived Exosome Therapeutics
-
Novel assay for early detection of ovarian cancer in extracellular vesicles significantly outperforms current standard test
-
Evox Therapeutics Presents Progress Across its DeliverEX™ Exosome Therapeutics Platform